surpass tirzepatide Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial Tirzepatide: A Systematic Update

Sci Adv 5:eaaw2238 Hao X, Shao Z, Zhang N, Jiang M, Cao X, Li S et al (2023) Integrative genome-wide analyses identify novel loci associated with kidney stones and provide insights into its genetic architecture

Safety and Efficacy : Regulatory agencies will require rigorous safety and efficacy data before approving Ipamrelin for clinical use

To provide a structured comparison of the inflammatory biomarkers discussed in MASLD, Table IV summarizes their biological roles, diagnostic relevance, and current limitations based on available evidence

It supports antioxidant activity, protecting immune cells from oxidative damage

Saunders, MD, DABOM , an obesity expert, co-founder of Intellihealth and a clinical assistant professor of Medicine at Weill Cornell Medicine

Several studies show improvements or slower declines in mental ability in people with Alzheimer's disease who took ALC